Document is current
Any future updates will be listed below
-
Authors
Sasi, Philip https://orcid.org/0000-0002-9911-8302
Makubi, Abel
Sangeda, Raphael Z. https://orcid.org/0000-0002-6574-5308
Ngaeje, Mariam Y.
Mmbando, Bruno P.
Soka, Joseph
Rosano, Caterina
Magesa, Alex S.
Cox, Sharon E.
Makani, Julie
Novelli, Enrico M.
-
Funding
Funding for this research was provided by:
Pitt | Vascular Medicine Institute, University of Pittsburgh (9011142 (710111 - 1).)
- License Information
-
More Information
Article History
Received: 4 April 2023
Accepted: 18 June 2024
First Online: 9 August 2024
Competing interests
: The sponsor had no role in any stage of the study, including study design, data analysis or manuscript preparation. E.M.N is a consultant/advisory board member for Novo Nordisk, Chiesi Pharmaceuticals and Shield Therapeutics.
